Structure of a nanobody-stabilized active state of the β2 adrenoceptor (original) (raw)
Accession codes
Primary accessions
Protein Data Bank
Data deposits
Coordinates and structure factors for β2AR–Nb80 are deposited in the Protein Data Bank (accession code 3P0G).
References
- Rosenbaum, D. M., Rasmussen, S. G. & Kobilka, B. K. The structure and function of G-protein-coupled receptors. Nature 459, 356–363 (2009)
Article ADS CAS Google Scholar - Scheerer, P. et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455, 497–502 (2008)
Article ADS CAS Google Scholar - Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. W. & Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183–187 (2008)
Article ADS CAS Google Scholar - Li, J., Edwards, P. C., Burghammer, M., Villa, C. & Schertler, G. F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409–1438 (2004)
Article CAS Google Scholar - Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science [see comments]. 289, 739–745 (2000)
Article ADS CAS Google Scholar - Vogel, R. & Siebert, F. Conformations of the active and inactive states of opsin. J. Biol. Chem. 276, 38487–38493 (2001)
Article CAS Google Scholar - Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into β-adrenergic receptor function. Science 318, 1266–1273 (2007)
Article ADS CAS Google Scholar - Rasmussen, S. G. et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450, 383–387 (2007)
Article ADS CAS Google Scholar - Cherezov, V. et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318, 1258–1265 (2007)
Article ADS CAS Google Scholar - Hanson, M. A. et al. A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor. Structure 16, 897–905 (2008)
Article CAS Google Scholar - Warne, T. et al. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 454, 486–491 (2008)
Article ADS CAS Google Scholar - Jaakola, V. P. et al. The 2.6 Angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211–1217 (2008)
Article ADS CAS Google Scholar - Ghanouni, P. et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J. Biol. Chem. 276, 24433–24436 (2001)
Article CAS Google Scholar - Rosenbaum, D. M. et al. Structure and function of an irreversible agonist–β2 adrenoceptor complex. Nature doi:10.1038/nature09665 (this issue).
- Yao, X. J. et al. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc. Natl Acad. Sci. USA 106, 9501–9506 (2009)
Article ADS CAS Google Scholar - Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446–448 (1993)
Article ADS CAS Google Scholar - Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Meth. Neurosci. 25, 366–428 (1995)
Article CAS Google Scholar - Strader, C. D. et al. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl Acad. Sci. USA 84, 4384–4388 (1987)
Article ADS CAS Google Scholar - Liapakis, G. et al. The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the β2-adrenergic receptor. J. Biol. Chem. 275, 37779–37788 (2000)
Article CAS Google Scholar - Wieland, K., Zuurmond, H. M., Krasel, C., Ijzerman, A. P. & Lohse, M. J. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. Proc. Natl Acad. Sci. USA 93, 9276–9281 (1996)
Article ADS CAS Google Scholar - Shi, L. et al. β2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277, 40989–40996 (2002)
Article CAS Google Scholar - Ahuja, S. & Smith, S. O. Multiple switches in G protein-coupled receptor activation. Trends Pharmacol. Sci. 30, 494–502 (2009)
Article CAS Google Scholar - Pellissier, L. P. et al. Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors. Mol. Pharmacol. 75, 982–990 (2009)
Article CAS Google Scholar - Altenbach, C., Kusnetzow, A. K., Ernst, O. P., Hofmann, K. P. & Hubbell, W. L. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc. Natl Acad. Sci. USA 105, 7439–7444 (2008)
Article ADS CAS Google Scholar - Parnot, C., Miserey-Lenkei, S., Bardin, S., Corvol, P. & Clauser, E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13, 336–343 (2002)
Article CAS Google Scholar - Kobilka, B. K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal. Biochem. 231, 269–271 (1995)
Article CAS Google Scholar - Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706–731 (2009)
Article CAS Google Scholar - Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997)
Article CAS Google Scholar - McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007)
Article CAS Google Scholar - Afonine, P. V., Grosse-Kunstleve, R. W. & Adams, P. D. A robust bulk-solvent correction and anisotropic scaling procedure. Acta Crystallogr. D 61, 850–855 (2005)
Article Google Scholar - Blanc, E. et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT . Acta Crystallogr. D 60, 2210–2221 (2004)
Article CAS Google Scholar - Whorton, M. R. et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl Acad. Sci. USA 104, 7682–7687 (2007)
Article ADS CAS Google Scholar
Acknowledgements
We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B.K.K.), GM56169 (W.I.W.), P01 GM75913 (S.H.G), and P60DK-20572 (R.K.S.), the Mathers Foundation (B.K.K. and W.I.W.), the Lundbeck Foundation (Junior Group Leader Fellowship, S.G.F.R.), the University of Michigan Biomedical Sciences Scholars Program (R.K.S.), the Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E.P. and J.S.).
Author information
Author notes
- Søren G. F. Rasmussen, Hee-Jung Choi and Juan Jose Fung: These authors contributed equally to this work.
Authors and Affiliations
- Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, 94305, California, USA
Søren G. F. Rasmussen, Hee-Jung Choi, Juan Jose Fung, Daniel M. Rosenbaum, Foon Sun Thian, Tong Sun Kobilka, William I. Weis & Brian K. Kobilka - Department of Neuroscience and Pharmacology, The Panum Institute, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark,
Søren G. F. Rasmussen - Department of Structural Biology, Stanford University School of Medicine, 299 Campus Drive, Stanford, 94305, California, USA
Hee-Jung Choi & William I. Weis - Department of Molecular and Cellular Interactions, Vlaams Instituut voor Biotechnologie (VIB), Vrije Universiteit Brussel, B-1050 Brussels, Belgium,
Els Pardon & Jan Steyaert - Structural Biology Brussels, Vrije Universiteit Brussel, B-1050 Brussels, Belgium ,
Els Pardon & Jan Steyaert - Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Paola Casarosa, Andreas Schnapp, Ingo Konetzki & Alexander Pautsch - Department of Chemistry, University of Wisconsin, Madison, 53706, Wisconsin, USA
Pil Seok Chae & Samuel H. Gellman - Department of Pharmacology, University of Michigan Medical School, Ann Arbor, 48109, Michigan, USA
Brian T. DeVree & Roger K. Sunahara
Authors
- Søren G. F. Rasmussen
You can also search for this author inPubMed Google Scholar - Hee-Jung Choi
You can also search for this author inPubMed Google Scholar - Juan Jose Fung
You can also search for this author inPubMed Google Scholar - Els Pardon
You can also search for this author inPubMed Google Scholar - Paola Casarosa
You can also search for this author inPubMed Google Scholar - Pil Seok Chae
You can also search for this author inPubMed Google Scholar - Brian T. DeVree
You can also search for this author inPubMed Google Scholar - Daniel M. Rosenbaum
You can also search for this author inPubMed Google Scholar - Foon Sun Thian
You can also search for this author inPubMed Google Scholar - Tong Sun Kobilka
You can also search for this author inPubMed Google Scholar - Andreas Schnapp
You can also search for this author inPubMed Google Scholar - Ingo Konetzki
You can also search for this author inPubMed Google Scholar - Roger K. Sunahara
You can also search for this author inPubMed Google Scholar - Samuel H. Gellman
You can also search for this author inPubMed Google Scholar - Alexander Pautsch
You can also search for this author inPubMed Google Scholar - Jan Steyaert
You can also search for this author inPubMed Google Scholar - William I. Weis
You can also search for this author inPubMed Google Scholar - Brian K. Kobilka
You can also search for this author inPubMed Google Scholar
Contributions
S.G.F.R. screened and characterized high affinity agonists, identified and determined dissociation rate of BI-167107, screened, identified and characterized MNG-3, performed selection and characterization of nanobodies, purified and crystallized the receptor with Nb80 in LCP, optimized crystallization conditions, grew crystals for data collection, reconstituted receptor in HDL particles and determined the effect of Nb80 and Gs on receptor conformation and ligand binding affinities, assisted with data collection and preparing the manuscript. H.-J.C. processed diffraction data, solved and refined the structure, and assisted with preparing the manuscript. J.J.F. expressed, purified, selected and characterized nanobodies, purified and crystallized receptor with nanobodies in bicelles, assisted with growing crystals in LCP, and assisted with data collection. E.P. performed immunization, cloned and expressed nanobodies, and performed the initial selections. J.S. supervised nanobody production. P.S.K. and S.H.G. provided MNG-3 detergent for stabilization of purified β2AR. B.T.D. and R.K.S. provided ApoA1 and Gs protein, and reconstituted β2AR in HDL particles with Gs. D.M.R. characterized the usefulness of MNG-3 for crystallization in LCP and assisted with manuscript preparation. F.S.T. expressed β2AR in insect cells and with T.S.K performed the initial stage of β2AR purification. A.P., A.S. assisted in selection of the high-affinity agonist BI-167107. I.K. synthesized BI-167,107. P.C. characterized the functional properties of BI-167,107 in CHO cells. W.I.W. oversaw data processing, structure determination and refinement, and assisted with writing the manuscript. B.K.K. was responsible for the overall project strategy and management, prepared β2AR in lipid vesicles for immunization, harvested and collected data on crystals, and wrote the manuscript.
Corresponding authors
Correspondence toWilliam I. Weis or Brian K. Kobilka.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
The file contains Supplementary Figures 1-6 with legends, Supplementary Tables 1-2 and additional references. (PDF 4062 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Rasmussen, S., Choi, HJ., Fung, J. et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor.Nature 469, 175–180 (2011). https://doi.org/10.1038/nature09648
- Received: 06 July 2010
- Accepted: 01 November 2010
- Published: 12 January 2011
- Issue Date: 13 January 2011
- DOI: https://doi.org/10.1038/nature09648